Skip to main content
Log in

Lyciumamide A, a dimer of phenolic amide, protects against NMDA-induced neurotoxicity and potential mechanisms in vitro

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

Currently, the excessive activation of N-methyl-D-aspartate receptors (NMDARs) is considered to be a crucial mechanism of brain injury. Lycium barbarum A (LyA) is a dimer of phenol amides isolated from the fruit of Lycium barbarum. Our previous studies have shown that LyA has potential antioxidant activity. This study aimed to explore the neuroprotective effect of LyA and its potential mechanism. Firstly, the molecular docking was used to preliminarily explore the potential function of LyA to block NMDAR. Then, the ability of LyA was further verified by NMDA-induced human neuroblastoma SH-SY5Y cells in vivo. Treatment with LyA significantly attenuated NMDA-induced neuronal insults by increasing cell viability, reducing lactate dehydrogenase (LDH) release, and increasing cell survival. Meanwhile, LyA significantly reversed the increase in intracellular calcium and in ROS production induced by NMDA. Finally, the western blot indicated that LyA could suppress the Ca2+ influx and increase the p-NR2B, p-CaMKII, p-JNK, and p-p38 level induced by NMDA. These above findings provide evidence that LyA protect against brain injury, and restraining NMDARs and suppressing mitochondrial oxidative stress and inhibiting cell apoptosis may be involved in the protective mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

NMDARs:

N-methyl-D-aspartate receptors

LyA:

Lyciumamide A

ROS:

Reactive oxygen species

CaMKII:

Calcium/calmodulin-dependent protein kinase II

References

Download references

Funding

This present study was supported by grants from the National Natural Science Foundation of China (Nos. 81603314 and 81703795), and Shaanxi Province Natural Science Basic Research Project (No. 2018JQ8065).

Author information

Authors and Affiliations

Authors

Contributions

KG, M-YL, YL, LW, CZ, XZ and J-YZ performed the experiment; H-FT conducted to extract these phenolic amides; Y-YJ, J-WW and A-DW conceived and designed the study; KG analyzed the data and generated the figures; KG, M-YL and YD wrote and edited the manuscript.

Corresponding authors

Correspondence to Yanyan Jia, Jingwen Wang or Aidong Wen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, K., Liu, M., Li, Y. et al. Lyciumamide A, a dimer of phenolic amide, protects against NMDA-induced neurotoxicity and potential mechanisms in vitro. J Mol Histol 52, 449–459 (2021). https://doi.org/10.1007/s10735-020-09952-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-020-09952-y

Keywords

Navigation